Results 281 to 290 of about 59,439 (317)
Some of the next articles are maybe not open access.

Cannabinoids

Current Drug Target -CNS & Neurological Disorders, 2005
Since the discovery of an endogenous cannabinoid system, research into the pharmacology and therapeutic potential of cannabinoids has steadily increased. Two subtypes of G-protein coupled cannabinoid receptors, CB(1) and CB(1), have been cloned and several putative endogenous ligands (endocannabinoids) have been detected during the past 15 years.
openaire   +2 more sources

Cannabinoids and Neuroprotection

Molecular Neurobiology, 2001
Cannabinoid compounds are endowed with pharmacological properties that make them interesting candidates for therapeutic development. These properties have been known since antiquity. However, in the last decade extremely important advances in the understanding of the physiology, pharmacology, and molecular biology of the cannabinoid system have given ...
Grundy, Robert   +2 more
openaire   +3 more sources

Cannabinoids and Anxiety

2009
The term cannabinoids encompasses compounds produced by the plant Cannabis sativa, such as delta9-tetrahydrocannabinol, and synthetic counterparts. Their actions occur mainly through activation of cannabinoid type 1 (CB1) receptors. Arachidonoyl ethanolamide (anandamide) and 2-arachidonoyl glycerol (2-AG) serve as major endogenous ligands ...
Moreira, F., Wotjak, C.
openaire   +3 more sources

Cannabinoid signalling

Life Sciences, 2006
After their discovery, the two known cannabinoid receptors, CB(1) and CB(2), have been the focus of research into the cellular signalling mechanisms of cannabinoids. The initial assessment, mainly derived from expression studies, was that cannabinoids, via G(i/o) proteins, negatively modulate cyclic AMP levels, and activate inward rectifying K ...
Dirk G, Demuth, Areles, Molleman
openaire   +2 more sources

Inflammaging and Cannabinoids

Ageing Research Reviews, 2021
Aging is a complex phenomenon associated with a wide spectrum of physical and physiological changes affecting every part of all metazoans, if they escape death prior to reaching maturity. Critical to survival, the immune system evolved as the principal component of response to injury and defense against pathogen invasions.
Babak, Baban   +8 more
openaire   +2 more sources

The cannabinoid receptors

Prostaglandins & Other Lipid Mediators, 2002
Cannabinoid receptors were named because they have affinity for the agonist delta9-tetrahydrocannabinol (delta9-THC), a ligand found in organic extracts from Cannabis sativa. The two types of cannabinoid receptors, CB1 and CB2. are G protein coupled receptors that are coupled through the Gi/o family of proteins to signal transduction mechanisms that ...
openaire   +2 more sources

The pyrolysis of cannabinoids

1987
Plants of the genus Cannabis are known to produce stronger and more immediate effects when smoked, the usual way of administration in Western countries, than when orally taken in similar amounts. In particular, the psychoactive effects are stronger than could be expected from the initial tetrahydrocannabinol (THC) content (Galanter et al.
openaire   +2 more sources

Cannabinoids and psychosis

International Review of Psychiatry, 2009
Recent advances in knowledge about cannabinoid receptor function have renewed interest in the association between cannabis and psychosis. Case series, autobiographical accounts, and surveys of cannabis users in the general population suggest an association between cannabis and psychosis.
R Andrew, Sewell   +2 more
openaire   +2 more sources

Synthetic Cannabinoids

The American Journal of the Medical Sciences, 2015
Synthetic cannabinoids (SCBs), also known under the brand names of "Spice," "K2," "herbal incense," "Cloud 9," "Mojo" and many others, are becoming a large public health concern due not only to their increasing use but also to their unpredictable toxicity and abuse potential.
Brooke, Mills   +2 more
openaire   +2 more sources

Cannabinoids and Pain

2007
Convincing evidence from preclinical studies demonstrates that cannabinoids can reduce pain responses in a range of inflammatory and neuropathic pain models. The anatomical and functional data reveal cannabinoid receptor-mediated analgesic actions operating at sites concerned with the transmission and processing of nociceptive signals in brain, spinal ...
I J, Lever, A S C, Rice
openaire   +2 more sources

Home - About - Disclaimer - Privacy